rTMS	rtms	O	O
of	of	O	O
supplementary	supplementary	O	O
motor	motor	O	O
area	area	O	O
modulates	modulates	O	O
therapy-induced	therapy-induced	O	O
dyskinesias	dyskinesias	O	S_disease
in	in	O	O
Parkinson	parkinson	O	B_disease
disease	disease	O	I_disease
.	.	O	O

The	the	O	O
neural	neural	O	O
mechanisms	mechanisms	O	O
and	and	O	O
circuitry	circuitry	O	O
involved	involved	O	O
in	in	O	O
levodopa-induced	levodopa-induced	O	O
dyskinesia	dyskinesia	O	S_disease
are	are	O	O
unclear	unclear	O	O
.	.	O	O

Using	using	O	O
repetitive	repetitive	O	O
transcranial	transcranial	O	O
magnetic	magnetic	O	O
stimulation	stimulation	O	O
(	(	O	O
rTMS	rtms	O	O
)	)	O	O
over	over	O	O
the	the	O	O
supplementary	supplementary	O	O
motor	motor	O	O
area	area	O	O
(	(	O	O
SMA	sma	O	O
)	)	O	O
in	in	O	O
a	a	O	O
group	group	O	O
of	of	O	O
patients	patients	O	O
with	with	O	O
advanced	advanced	O	O
Parkinson	parkinson	O	B_disease
disease	disease	O	I_disease
,	,	O	O
the	the	O	O
authors	authors	O	O
investigated	investigated	O	O
whether	whether	O	O
modulation	modulation	O	O
of	of	O	O
SMA	sma	O	O
excitability	excitability	O	O
may	may	O	O
result	result	O	O
in	in	O	O
a	a	O	O
modification	modification	O	O
of	of	O	O
a	a	O	O
dyskinetic	dyskinetic	O	O
state	state	O	O
induced	induced	O	O
by	by	O	O
continuous	continuous	O	O
apomorphine	apomorphine	S_chemical	O
infusion	infusion	O	O
.	.	O	O

rTMS	rtms	O	O
at	at	O	O
1	1	O	O
Hz	hz	O	O
was	was	O	O
observed	observed	O	O
to	to	O	O
markedly	markedly	O	O
reduce	reduce	O	O
drug-induced	drug-induced	O	O
dyskinesias	dyskinesias	O	S_disease
,	,	O	O
whereas	whereas	O	O
5-Hz	5-hz	O	O
rTMS	rtms	O	O
induced	induced	O	O
a	a	O	O
slight	slight	O	O
but	but	O	O
not	not	O	O
significant	significant	O	O
increase	increase	O	O
.	.	O	O

